Dr. Albert Friesen | CEO |
Dr. Neil Owens | President and COO |
Haaris Uddin | CFO |
Kurt Caramanidis | Carl M. Hennig, Inc. |
Good morning, ladies and gentlemen and welcome to Medicure’s Earnings Conference Call for the Quarter Ended September 30, 2022. My name is Michelle and I’ll be your operator for today’s call. At this time, all participants are in listen-only mode.
Before we proceed, I would like to remind everyone that this presentation contains forward-looking statements relating to future results, events and expectations, which are made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.